These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31932816)

  • 1. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
    Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
    Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics-On-a-Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME.
    Ramadan Q; Fardous RS; Hazaymeh R; Alshmmari S; Zourob M
    Adv Biol (Weinh); 2021 Sep; 5(9):e2100775. PubMed ID: 34323392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.
    Sutherland ML; Fabre KM; Tagle DA
    Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):I1. PubMed ID: 24565163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
    Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
    Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging microphysiological systems: a review.
    Peel S; Jackman M
    Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation.
    Somayaji MR; Das D; Przekwas AJ
    Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
    Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences.
    Van Ness KP; Cesar F; Yeung CK; Himmelfarb J; Kelly EJ
    Clin Transl Sci; 2022 Jan; 15(1):9-42. PubMed ID: 34378335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
    Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
    Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
    Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
    Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Development in Organ-On-A-Chip Technology.
    Joseph X; Akhil V; Arathi A; Mohanan PV
    J Pharm Sci; 2022 Jan; 111(1):18-31. PubMed ID: 34324944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.